Status
Conditions
Treatments
About
This study aims to assess the reliability of measurement of mass change in serum albumin compared to serum lactic acid as predictive tool for sepsis prognosis in nonsurgical ICU patients
Full description
This study explores the prognostic value of mass change in serum albumin compared to serum lactic acid levels in non-surgical ICU patients with sepsis. While serum lactate is an established marker of tissue hypo-perfusion and a predictor of sepsis outcomes, serum albumin is less frequently used for dynamic monitoring, although it is known to correlate with severity and mortality
Measurements:
Data Collection:
A-Baseline Data on ICU Admission:
Demographics: age, sex
Comorbidities (e.g., diabetes, hypertension, chronic kidney disease)
Initial hemodynamic parameters (BP-HR-SO2-ECG-UOP-TEMP-RR)
diagnosis of sepsis involves recognising signs of infection plus organ dysfunction according to SSC and sepsis -3
A- Search about source of infection by:
SOFA Score range:
0-6: low risk of organ failure 7-12: moderate risk >12: high risk of mortality
initial reading of serum albumin in admission (T0)
initial reading of albumin creat ratio (ACR)as tool for measuring albumin in urine Patients with severe albuminuria will be excluded from the study
Daily measurements:
3-24HR Fluid balance.
C- Daily recordings:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal